Simultaneous Quantification of the Newly FDA Approved Antibiotic Combination for the Treatment of Complicated Infections (Ceftolozane and Tazobactam) either in Pure Form or in their Dosage Form

Pharmacology, Toxicology and Pharmaceutical Science

1. Antimicrobial Agent 100%
2. Antibiotic Agent 100%
3. Dosage Form 100%
4. Urinary Tract Infection 66%
5. Antiinfective Agent 33%
6. Penicillinase 27%
7. Infectious Agent 22%
8. Cephalosporin 22%
9. Diseases 16%
10. Chemotherapy 16%
11. Pharmacokinetic 11%
12. Infection 11%
13. Gram Negative Bacterium 11%
14. Normal Human 5%
15. Bacterial Pneumonia 5%
16. Excipient 5%
17. Enterobacteriaceae 5%
18. Fetus Death 5%
19. Meropenem 5%
20. Pseudomonas aeruginosa 5%
21. Table Salt 5%
22. Structure Activity Relationship 5%
23. Arginine 5%
24. Metronidazole 5%
25. Klebsiella pneumoniae 5%
26. High Performance Liquid Chromatography 5%
27. Bacterial Infection 5%
28. Mortality Rate 5%
29. Prevalence 5%
30. Combination Therapy 5%
31. Agar 5%
32. Premature Labor 5%
33. Escherichia coli 5%
34. Stabilizing Agent 5%